Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Sep 1;27(9):euaf161.
doi: 10.1093/europace/euaf161.

Pulsed field ablation for ventricular tachycardia: are we there yet?

Luigi Di Biase  1 , Jose Merino  2 , Andrea Natale  3   4
Affiliations
Editorial

Pulsed field ablation for ventricular tachycardia: are we there yet?

Luigi Di Biase et al. Europace. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: L.D.B. has served as a consultant for Biosense Webster, Inc., Stereotaxis, I-Rhythm, Abbott, Boston Scientific, Medtronic, Biotronik, AtriCure, Haemodinamics, Siemens, and Zoll Medical. J.M. has received speaker fees and honoraria for lectures and scientific advice from Biotronik, Medtronic, Microport, Milestone Pharmaceutical, Sanofi, and Zoll. A.N. is a consultant for Abbott, Biosense Webster, Biotronik, Boston Scientific, Field Medical, iRhythm, Hemonetics, Medtronic, and Pulse Bioscience.

Figures

Central illustration.
Central illustration.
Potential advantages of pulsed field ablation for ventricular tachycardia ablation.
See this image and copyright information in PMC

Comment on

References

    1. Della Bella P, Baratto F, Vergara P, Bertocchi P, Santamaria M, Notarstefano P et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 2022;145:1829–38. - PubMed
    1. Schiavone M, Gasperetti A, Compagnucci P, Vogler J, Laredo M, Montemerlo E et al. Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project. Europace 2024;26:euae066. - PMC - PubMed
    1. Natale A, Zeppenfeld K, Della Bella P, Liu X, Sabbag A, Santangeli P et al. Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward. Europace 2023;25:euad225. - PMC - PubMed
    1. Sapp JL, Tang ASL, Parkash R, Stevenson WG, Healey JS, Gula LJ et al. Catheter ablation or antiarrhythmic drugs for ventricular tachycardia. N Engl J Med 2025;392:737–47. - PubMed
    1. Arya A, Di Biase L, Bazán V, Berruezo A, d'Avila A, Della Bella P et al. Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society. Europace 2025;27:euaf055. - PMC - PubMed

LinkOut - more resources